A 384-HTS for human factor VIIa: Comparison with 96- and 864-well formats

Journal of Biomolecular Screening

Volumn 2, Issue 3, 1997, Pages 171-178

  Comley, John C W ^a   Binnie, Alastair ^a   Bonk, Caroline ^a   Houston, John G ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001336521     PISSN: 10870571     EISSN: None     Source Type: Journal    
DOI: 10.1177/108705719700200307     Document Type: Article

References (13)

1. Kario, K., Miyata, T., Sakata, T., Matsuo, T., Kato, H. (1994). Fluorogenic assay of activated factor VII. Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese. Arterioscler. Thromb. 14:265-274.
2. Lawson, J. H., Butenas, S., Mann, K. G. (1992). The evaluation of complex-dependent alterations in Human factor VIIa. J. Biol. Chem. 267:4834-4843.
3. Neuenschwander, P. F., Branam, D. E., Morrissey, J. H. (1993). Importance of substrate composition, pH and other variables on tissue factor enhancement of factor Vila activity. Thromb. Haemost. 70:970-977.
4. Ruf, W., Rehemtulla, A., Morrissey, J. H., Edgington, T. S. (1991). Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function. J. Biol. Chem. 266:2158-2166.
5. Butenas, S., Orfeo, T., Lawson, J. H., Mann, K. G. (1992). Aminonaphthalenesulfonamides, a new class of modifiable fluorescent detecting groups and their use in substrates for serine protease enzymes. Biochemistry 31:5399-5411.
6. Butenas, S., Ribarik, N., Mann, K. G. (1993). Synthetic substrates for human factor VIIa and factor VIIa-tissue factor. Biochemistry 32:6531-6538.
7. Hook, D. (1996). Ultra high-throughput screening - A journey into nanoland with Gulliver and Alice. Drug Discovery Today 1:267-268.
8. Wallace, R. W. (1996). Packard and Aurora Biosciences to codevelop ultra-HTS technologies. Drug Discovery Today 1:313-314.
9. Rigler, R. (1995). Fluorescence correlations, single molecule detection and large number screening-Application in Biotechnology J. Biotechnology 41:177-186.
10. Janzen, B., Domanico, P. (1996). The 384-well plate: Pros and cons. J. Biomolecular Screening 1:63-64.
11. Klob, A. J., Neumann, K. (1996). Radioisotopic and luminescence counting in 384-96-well microplates. Network Science, Feature 7.
12. Burbaum, J. J. (1997). Implementation of microvolume assays in high-density microtitre plates. Lab Automation 97. San Diego, CA, January 18-22, 1997.
13. Banks, M., Fogarty, S., Valler, M., Mills, K., O'Brien, S., Binnie, B., Houston, J. (1996). Automated high throughput screening to aid the drug hunter at GlaxoWellcome. Islar'96, Boston MA, October 20-23, 1996.